摘要
目的 评价半导体激光经巩膜睫状体光凝治疗难冶性青光眼的效果。方法 对32例难治性青光眼进行半导体激光睫状体光激治疗，能量1．5～2．0W，时间0．5～1s，范围180°～360°，点数12～28点。结果 观察6～10个月，治疗前眼压为33．8～63．7mmHg，平均（49．2±9．7）mmHg；第一次治疗后眼压为（12．1～36．2）mmHg，平均（20．1±6．3）mmHg；最后随诊眼压为10．6～33．4mmHg，平均（19．6±7．2）mmHg，明显低于术前（P〈0．01）；24例眼压下降≥30％，手术成功率75％，疼痛缓解率90．6％；并发症主要是葡萄膜炎及前房出血。结论 半导体激光经巩膜睫状体光凝治疗难治性青光眼，降眼压疗效确切，疼痛缓解率高，并发症少，可重复治疗。
Objective To evaluate the effect of transscleral diode laser cyelophotocoagulation on eyes with refractory glaucoma.Methods 32 eyes with refractory glaucoma were received the laser treatments with 1.5 ～ 2.0W for 0.5～ 1 seconds, ranging 180°～ 360°, 12 ～ 28 spots. Results The patients were followed six to ten months, lOP were 49.2 ± 9.7 mmHg（33.8 ～ 63.7 mmHg） before treatment, lOP were 20.1 ± 6.3 mmHg（ 12.1 ～ 36.2 mmHg） after first time of treatment and 19.6 ± 7.2 mm/tg（ 10.6 ～ 33.4 mmHg） at final follow-up, IOP was significandy decreased by transscleral diode laser cyclophotocoagulation（ P 〈 0.01）. The descent rate of IOP of 24 eyes was ≥30% .The success rate of surgery was 75 %, and the alleviation rate of pain was 90.6% ;The most common complications were anterior chamber reaction and uveitis. Conclusions Transscleral diode laser eyelophotocoagulation is a safe and effective therapy for the management refractory glaucoma, and it can relieve pain without serious complieations.
出处
《广西医学》
CAS
2006年第9期1344-1346,共3页
Guangxi Medical Journal
基金
广西科学基金项目(桂科基0342023)
